"The Trump administration is in a race to outpace the coronavirus as it seeks to replenish the country's national supply stockpile, despite conflicting messaging from officials about the potential severity of a second wave of the virus."


https://www.cnn.com/2020/06/23/politics/coronavirus-supply-strategic-national-stockpile/index.html?utm_source=fbCNN&utm_medium=social&utm_content=2020-06-23T19%3A29%3A10&utm_term=link

Healthcare Transactions Totaling $12,000,000

"We are excited to partner with CGL Global and ODOO to provide needed medical supplies including (PPE) direct from manufacturers to help in the fight of COVID-19 in Germany and countries across Europe. We have completed healthcare transactions globally totaling $12,000,000, and look forward to growing this with products across Europe, specifically with this current focus on much needed PPE equipment to help medical professionals and labor forces stay diligent and safe during this uncertain period" stated John Kupice CEO/Director H-Source Holdings, Ltd.

H-Source announces HSource1 In Europe for Medical Supplies and COVID-19

News provided by
H-Source Holdings Ltd.

May 12, 2020, 20:38 ET

Share this article

VANCOUVER, May 12, 2020 /CNW/ - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce the release of HSource1, its state of the art healthcare supplies platform, now online in the European Union (www.hsource1.eu), as part of an overall strategy to improve supply chain efficiency. The platform is focused on providing a central location for hospitals, governments, and businesses to procure highly needed medical supplies including medical surgical supplies, pharmaceuticals, capital equipment, and Personal Protective Equipment ("PPE") products for Germany and across Europe. The Company has partnered with CGL Global ("CGL"), who is procuring verified sourcing of products as well as providing fully integrated delivery channels across Europe. HSource1 is a private network, and all members and products are vetted by H-Source, increasing the accuracy and confidence of all participants, including buyers and sellers. Additionally, H-Source is working jointly with ODOO on the Hsource1 platform. The combined efforts of H-Source's healthcare focus and CGL Globals' various supply chain relationships, integrated with ODOO's technical resources, have created a unique platform to support a variety of solutions for front-line emergency workers and healthcare professionals during this COVID-19 pandemic.

"We are proud to help and partner with associations and businesses that fight the COVID-19 crisis. Our new partner H-Source will have a positive impact by helping hospitals and government healthcare facilities stay safe during this crisis" commented Fabien Pinckaers, Founder and CEO of ODOO.

"We are excited to partner with CGL Global and ODOO to provide needed medical supplies including (PPE) direct from manufacturers to help in the fight of COVID-19 in Germany and countries across Europe. We have completed healthcare transactions globally totaling $12,000,000, and look forward to growing this with products across Europe, specifically with this current focus on much needed PPE equipment to help medical professionals and labor forces stay diligent and safe during this uncertain period" stated John Kupice CEO/Director H-Source Holdings, Ltd.

About CGL Global
CGL Global is a vertically integrated international company focused in the Healthcare Sector. CGL Global partners with various Research & Development facilities, Universities, Healthcare Professionals, Government Agencies and cutting-edge technology focused Companies to engage in the development and commercialization of various therapeutic formulations for the Pharmaceutical & Medicinal sectors, as well as developing Health and Wellness products using innovative, patent-protected drug delivery technologies. Our Vision and Mission is focused on allowing people to live their very best lives.

About ODOO
Odoo is a leading provider of all-in-one, open-source business software for businesses worldwide. Founded in 2005, Odoo thrives in a unique and fully open ecosystem combining the resources of its community and partners to deliver a full range of easy-to-use, integrated and scalable business applications. Odoo has offices in the U.S., Belgium, Luxembourg, India, Hong Kong, and Dubai. For more information, please visit: www.odoo.com.

About H-Source Holdings Ltd.
H-Source Holdings Ltd. is a proprietary, patented technology company operating within the healthcare industry through its wholly-owned subsidiary, H-Source, Inc. The Company has developed an advanced technology solutions stack that provides participating members a private, secure, Software As A Service ("SAAS") platform to engage in the buy, sell, track, and transfer of medical supplies, pharmaceuticals, capital equipment, and medical devices. Integrating advanced Artificial Intelligence ("AI") and Business Intelligence ("BI") enhance the data analytics for supply chain optimization. The platform is FDA and DSCSA compliant for pharmaceuticals and GS-1 UDI/GTIN for devices including serialization, ownership, and custody in extended modules. Blockchain is offered as an add-on, at an additional cost, for robust security and traceability. Additionally, the H-Source platform provides all the accounting and data allowing buyers and sellers to capture product transactions and custody movements. This platform is designed to increase and maximize supply chain efficiency while reducing costs by moving products directly from manufacturers, providers, and distributors to businesses or consumers. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice
CEO & Director

H-Source Holdings launches new website and opens East Coast office...

https://www.h-source.com/

H-Source MD&A

The most important announcement early in Q4 is our partnering with EY (one of the “Big 4” global service providers) to deploy the H-Source software platform on the EY OpsChain Blockchain platform. We are jointly marketing opportunities related to supply chain transformation for medical supplies, equipment, and pharmaceuticals. This is core to our strategic plan to pivot to more software engagements. The joint projects will include license fees, transaction fees, and success or shared risk fees. We expect revenue from this initiative starting late Q1 of 2020. We are bringing a global nutraceutical distributor live on the H-Source platform in Europe and Canada late in Q4 of 2019. This is a project that showcases our global functionality including:

1.Ability to host and transact in the European Union with localization for language and currency

2.Track and trace capability for FDA and Swiss medical products

3.Provide a Canadian distribution network for products in local currency

4.Positive impact in 2020 as we help the distributor expand its global operations. We have added 20 independent sales representatives as of mid-November of 2019. We hope to see impacts from these representatives in Q1 of 2020.

Currently, H-Source pursues its growth strategy by:

•Continue with the Pilot of the H-Source/EY platform on OpsChain

•Add experienced software professionals to assist with software engagement acquisition and delivery experience on a variable compensation model (“eat what you kill”) based on profitability

•Expand existing software engagement pipeline for the joint H-Source/EY product offering

•Deploying independent sales representatives in select markets to enhance sales and convert contracted facilities to active facilities on the H-Source platformoFocusing on listing products that turn faster at predictable prices and marginsoOffering additional enhanced services to our clients where H-Source provides additional touch –labor for higher transaction fees with the addition of independent sales representatives

•Continue to expand Nutraceutical clients

•Maintaining Joint Marketing relationships with multiple state hospital associations and metropolitan hospital councils and associations

•Licensing our platform to medical facilities plus transaction fees

•Distributing products from third parties or Original Equipment Manufacturers (“OEM”) thru the platform

H-Source another Amazon

H-Source another Amazon...

"Aside from excess inventories, the Company has also addressed the possibility of including OEM and/or third party products on the platform. This one is interesting to us, but we think it also has some caveats that we won’t belabor but will at least address. First, establishing a virtual marketplace where a host of enterprises can market/sell their products to others is a proven model. Amazon is of course the glaring example although there are certainly others as well. That approach has been especially attractive to sellers (largely businesses and/or OEMs) that may lack the ability to afford and/or scale broad marketing and distribution campaigns. Clearly there are examples of products that experienced wild success that absent the Amazon platform would likely never have done so. While selling OEM healthcare products in a virtual marketplace certainly has some unique caveats that for instance, selling a winter coat on Amazon may not, there are some similarities worth noting. In the end, since the advent of the internet, many industries have seen their legacy distribution chains disintermediated, disrupted and even dismantled because of the efficiencies and the transparencies provided by open virtual markets. In an industry rife with inefficiency, it is almost hard to believe that healthcare supply chains have not been dragged kicking and screaming into the same paradigm. Again, we think there are good reasons why healthcare supply chains have not been substantially impacted by technology, but there are also good reasons why they should be and as with other industries, the good reasons often boil down to better transparency. Increased transparency is not always good for everyone in an industry. Like the mandating of electronic medical records technology, we suspect healthcare is going to find itself in the cross hairs of additional technological change, either as a matter of economic necessity, government edict or both. We can see advantages for (some) OEMs as well as for their customers to utilize exchanges/platforms like H-Sources and we can envision some resistance as well."

It looks like something is up...

Anything going on here?

Over 500 medical facilities are now contracted (~10% of the US Hospital Market) with 300 onboard the platform

· Medical facilities are now actively transacting with increasing volumes

H-Source Announces Increasing Transaction Volume and Corporate Update

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 6, 2017) - H-Source Holdings Ltd. (TSX VENTURE:HSI)(OTCQB:HSCHF) (the "Company" or "H-Source") is pleased to announce that during the quarter over 500 medical facilities are now contracted for the platform resulting in increased transaction volume.

"We set strong objectives for fiscal 2017 including, increasing our network by adding hospitals and medical facilities, monetizing the H-Source platform, strengthening our technology enhancements, and supporting greater supply chain cost recovery and savings. We have made progress in the first half of the year and will continue to execute our growth plan by adding a diverse array of medical facilities to the platform, strengthen inventory offerings and increase transaction volumes. Transactions that started in the second quarter will continue to grow moving forward. Additionally, we are now able to leverage and expand the H-Source Platform in new ways that will become more evident in upcoming quarters," said John Kupice, CEO and director of H-Source.

Key milestones and for the first half of fiscal 2017 include:

· We are experiencing repeated participation from member facilities and continue to add functionality and services that drive increased adoption.

· Our platform includes over 300 medical facilities, that are now onboarded, our number of mature and transacting facilities continues to grow as we add new customers and implement our account management program. Our expanded platform functionality and support resulted in higher customer interaction that resulted in increased network inventory and liquidity. Customer use is a key metric that has showed steady uptick quarter over quarter.

· We continue to add functionality and scalability to the H-Source Platform at a measured pace to ensure our offering is enhanced and the customer experience remains exceptional. Specifically, we expanded our ability beyond managing idle inventory for hospitals and are now targeting a broader portion of the medical supply chain for a variety of medical facilities. We are in discussions or implementation phase with multiple new customers, including large Hospital IDNs (Integrated Delivery Networks) and State hospital associations. This expanded offering provides potential licensing revenue and increased transactions.

· Our previously announced partnership with BidMed has been a success and provides a unique solution and value to our customers which includes sourcing capital equipment, capital asset valuation, tracking, and liquidation services. We are looking forward to the upcoming quarters as we continue to grow our joint service offerings.

About H-Source Holdings Ltd.

H-Source Holdings Ltd. is a technology company operating within the healthcare industry through its wholly owned subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and trusted marketplace for member hospitals to buy, sell and transfer devices, pharmacuiticals, capital equipment and supplies with each other. Member hospitals can conduct secure transactions within Integrated Delivery Networks, complete H-Source network or customize their own group hospitals using H-Source's built-in filters. This marketplace network is specifically designed to reduce health care costs and medical product waste. For more information, please visit http://h-source.com/.

On behalf of the board of directors of H-Source Holdings Ltd.

John Kupice, CEO & Director

CAUTIONARY DISCLAIMER STATEMENT: The TSXV has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

This news release contains forward-looking statements relating to the completion of the listing of the Company's shares on the TSXV and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the TSXV and other risks detailed from time to time in the filings made by the Company with securities regulations.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
CONTACT INFORMATION

· H-Source Holdings Ltd.
John Kupice
CEO & Director
1-888-900-4549
jkupice@h-source.com

Nicole Marchand
416-428-3533
investors@h-source.com





Nicole Marchand

Investor Relations

t. (416) 428-3533

e.nicole@nm-ir.com